Chemical proteomics and discovery of drug targets

Yaoxue Xuebao

Volumn 46, Issue 8, 2011, Pages 877-882

  Yang, Hong Qin ^a,b   Xue jun, L I ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b Baoshan College   (China)

Author keywords

Chemical proteomics; small molecule; drug target; drug discovery

Indexed keywords

CHEMICAL ANALYSIS; DRUG INDUSTRY; DRUG RESEARCH; DRUG TARGETING; PROTEOMICS; REVIEW;

ANIMALS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; DRUG DISCOVERY; DRUGS, CHINESE HERBAL; HUMANS; PROTEIN ARRAY ANALYSIS; PROTEOMICS; SMALL MOLECULE LIBRARIES;

EID: 80053527549     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Lomenick B, Olsen RW, Huang J. Identification of direct protein targets of small molecules [J]. ACS Chem Biol, 2011, 6: 34-46.
2. Jeffery DA, Bogyo M. Chemical proteomics and its application to drug discovery [J]. Curr Opin Biotechnol, 2003, 14: 87-95. (Pubitemid 36151848)
3. Adam GC, Sorensen EJ, Cravatt BF. Chemical strategies for functional proteomics [J]. Mol Cell Proteomics, 2002, (10): 781-790.
4. Strassberger V, Fugmann T, Neri D, et al. Chemical proteomic and bioinformatic strategies for the identification and quantification of vascular antigens in cancer [J]. J Proteomics, 2010, 73: 1954-1973.
5. Rix U, Superti-Furga G. Target profiling of small molecules by chemical proteomics [J]. Nat Chem Biol, 2009, 5: 616-624.
6. Cheung AK, Jain RK. Accelerating the discovery of new drug targets with chemical proteomics [J]. IDrugs, 2010, 13: 862-868.
7. Zhou HX, Rivas G, Minton AP. Macromolecular crowding and confinement: biochemical, biophysical, and potential physiological consequences [J]. Annu Rev Biophys, 2008, 37: 375-397.
8. Mallick P, Kuster B. Proteomics: a pragmatic perspective [J]. Nat Biotechnol, 2010, 28: 695-709.
9. Zhang J, Yang PL, Gray NS. Targeting cancer with small molecule kinase inhibitors [J]. Nat Rev Cancer, 2009, 9: 28-39.
10. Lamb J, Crawford ED, Peck D, et al. The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease [J]. Science, 2006, 313: 1929-1935. (Pubitemid 44497995)
11. Terstappen GC, Schlüpen C, Raggiaschi R, et al. Target deconvolution strategies in drug discovery [J]. Nat Rev Drug Discov, 2007, 6: 891-903. (Pubitemid 350042397)
12. Verfielst SH, Bogyo M. Chemical proteomics applied to target identification and drug discovery [J]. Biotechniques, 2005, 38: 175-177. (Pubitemid 40216371)
13. Böttcher T, Pitscheider M, Sieber SA. Natural products and their biological targets: proteomic and metabolomic labeling strategies [J]. Angew Chem (Int Ed Engl), 2010, 49: 2680-2698.
14. Sato S, Murata A, Shirakawa T, et al. Biochemical target isolation for novices: affinity-based strategies [J]. Chem Biol, 2010, 17: 616-623.
15. Lomenick B, Hao R, Jonai N, et al. Target identification using drug affinity responsive target stability (DARTS) [J]. Proc Natl Acad Sci USA, 2009, 106: 21984-21989.
16. Hopkins AL. Network pharmacology [J]. Nat Biotechnol, 2007, 25: 1110-1111. (Pubitemid 47538107)
17. Huang J, Zhu H, Haggarty SJ, et al. Finding new components of the target of rapamycin (TOR) signaling network through chemical genetics and proteome chips [J]. Proc Natl Acad Sci USA, 2004, 101: 16594-16599. (Pubitemid 39557758)
18. Merbl Y, Kirschner MW. Protein microarrays for genome-wide posttranslational modification analysis [J]. Wiley Interdiscip Rev Syst Biol Med, 2011, 3: 347-356.
19. Barabási AL, Oltvai ZN. Network biology: understanding the cell's functional organization [J]. Nat Rev Genet, 2004, 5: 101-113. (Pubitemid 38160277)
20. Myers S, Baker A. Drug discovery - an operating model for a new era [J]. Nat Biotechnol, 2001, 19: 727-730.
21. Greenbaum DC, Baruch A, Grainger M, et al. A role for the protease falcipain 1 in host cell invasion by the human malaria parasite [J]. Science, 2002, 298: 2002-2006. (Pubitemid 35425258)
22. Zhang XW, Yan XJ, Zhou ZR, et al. Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML [J]. Science, 2010, 328: 240-243.
23. Yue RC, Shan L, Yan SK, et al. Application of chemical proteomics in the modernization of traditional Chinese medicine [J]. World Sci Technol Mod Tradit Chin Med, 2010, 12: 502-510.
24. Wang L, Zhou GB, Liu P, et al. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia [J]. Proc Natl Acad Sci USA, 2008, 105: 4826-4831. (Pubitemid 351753831)